150 related articles for article (PubMed ID: 3103712)
41. B4, a human B lymphocyte-associated antigen expressed on normal, mitogen-activated, and malignant B lymphocytes.
Nadler LM; Anderson KC; Marti G; Bates M; Park E; Daley JF; Schlossman SF
J Immunol; 1983 Jul; 131(1):244-50. PubMed ID: 6408173
[TBL] [Abstract][Full Text] [Related]
42. B-cell lymphomas of high-grade malignancy frequently lack HLA-DR, -DP and -DQ antigens and associated invariant chain.
Momburg F; Herrmann B; Moldenhauer G; Möller P
Int J Cancer; 1987 Nov; 40(5):598-603. PubMed ID: 3316049
[TBL] [Abstract][Full Text] [Related]
43. [Bone marrow immunophenotypes of 112 cases of lymphoid system malignant diseases].
Ling JY; Sun XF; Yan SL; He LR; Zhen ZJ; Xia Y
Ai Zheng; 2007 Apr; 26(4):418-22. PubMed ID: 17430665
[TBL] [Abstract][Full Text] [Related]
44. HD39 (B3), a B lineage-restricted antigen whose cell surface expression is limited to resting and activated human B lymphocytes.
Dörken B; Moldenhauer G; Pezzutto A; Schwartz R; Feller A; Kiesel S; Nadler LM
J Immunol; 1986 Jun; 136(12):4470-9. PubMed ID: 3086431
[TBL] [Abstract][Full Text] [Related]
45. Phenotypic heterogeneity of B- and T-cell differentiation antigens in B-CLL.
Merle-Beral H; Blanc C; Chastang C; Debre P
Eur J Haematol; 1988 Sep; 41(3):197-203. PubMed ID: 3263283
[TBL] [Abstract][Full Text] [Related]
46. Discordant expression of immunoglobulin and its associated molecule mb-1/CD79a is frequently found in mediastinal large B cell lymphomas.
Kanavaros P; Gaulard P; Charlotte F; Martin N; Ducos C; Lebezu M; Mason DY
Am J Pathol; 1995 Mar; 146(3):735-41. PubMed ID: 7887454
[TBL] [Abstract][Full Text] [Related]
47. Expression of human B cell-associated antigens on leukemias and lymphomas: a model of human B cell differentiation.
Anderson KC; Bates MP; Slaughenhoupt BL; Pinkus GS; Schlossman SF; Nadler LM
Blood; 1984 Jun; 63(6):1424-33. PubMed ID: 6609729
[TBL] [Abstract][Full Text] [Related]
48. Defective expression of MHC class I antigens is frequent in B-cell lymphomas of high-grade malignancy.
Möller P; Herrmann B; Moldenhauer G; Momburg F
Int J Cancer; 1987 Jul; 40(1):32-9. PubMed ID: 3298077
[TBL] [Abstract][Full Text] [Related]
49. Pathobiology of primary mediastinal B-cell lymphoma.
Pileri SA; Zinzani PL; Gaidano G; Falini B; Gaulard P; Zucca E; Sabattini E; Ascani S; Rossi M; Cavalli F;
Leuk Lymphoma; 2003; 44 Suppl 3():S21-6. PubMed ID: 15202521
[TBL] [Abstract][Full Text] [Related]
50. Primary mediastinal large cell lymphoma.
Rodriguez J; Pugh WC; Romaguera JE; Cabanillas F
Hematol Oncol; 1994; 12(4):175-84. PubMed ID: 8001905
[TBL] [Abstract][Full Text] [Related]
51. Most null large cell lymphomas are B lineage neoplasms.
Cleary ML; Trela MJ; Weiss LM; Warnke R; Sklar J
Lab Invest; 1985 Nov; 53(5):521-5. PubMed ID: 3932778
[TBL] [Abstract][Full Text] [Related]
52. Nodular lymphocyte predominance type of Hodgkin's disease is a B cell lymphoma.
Poppema S; Timens W; Visser L
Adv Exp Med Biol; 1985; 186():963-9. PubMed ID: 2931963
[No Abstract] [Full Text] [Related]
53. Phenotypic analysis by flow cytometry of surface immunoglobulin light chains and B and T cell antigens in lymph nodes involved with non-Hodgkin's lymphoma.
Liendo C; Danieu L; Al-Katib A; Koziner B
Am J Med; 1985 Oct; 79(4):445-54. PubMed ID: 3931469
[TBL] [Abstract][Full Text] [Related]
54. Differentiation of human myeloid leukemia cell lines induced by tumor-promoting phorbol ester (TPA). I. Changes of the morphology, cytochemistry and the surface differentiation antigens analyzed with monoclonal antibodies.
Stöckbauer P; Malasková V; Soucek J; Chudomel V
Neoplasma; 1983; 30(3):257-72. PubMed ID: 6346116
[TBL] [Abstract][Full Text] [Related]
55. Correlation of monoclonal antibody phenotyping and cellular DNA content in non-Hodgkin's lymphoma. The Southeastern Cancer Study Group experience.
Wain SL; Braylan RC; Borowitz MJ
Cancer; 1987 Nov; 60(10):2403-11. PubMed ID: 3499212
[TBL] [Abstract][Full Text] [Related]
56. Clinicopathologic study of primary mediastinal non-lymphoblastic non-Hodgkin's lymphomas among the Japanese.
Nakagawa A; Nakamura S; Koshikawa T; Nakayama A; Nagasaka T; Motoori T; Kojima M; Hosomura Y; Ueda R; Mori S
Acta Pathol Jpn; 1993; 43(1-2):44-54. PubMed ID: 8465656
[TBL] [Abstract][Full Text] [Related]
57. Primary mediastinal non-Hodgkin's lymphomas: a morphologic and immunologic study of 19 cases.
Yousem SA; Weiss LM; Warnke RA
Am J Clin Pathol; 1985 Jun; 83(6):676-80. PubMed ID: 3923821
[TBL] [Abstract][Full Text] [Related]
58. Immunophenotyping of non-Hodgkin's lymphoma. Lack of correlation between immunophenotype and cell morphology.
Schuurman HJ; van Baarlen J; Huppes W; Lam BW; Verdonck LF; van Unnik JA
Am J Pathol; 1987 Oct; 129(1):140-51. PubMed ID: 3310650
[TBL] [Abstract][Full Text] [Related]
59. Two new monoclonal antibodies (LN-1, LN-2) reactive in B5 formalin-fixed, paraffin-embedded tissues with follicular center and mantle zone human B lymphocytes and derived tumors.
Epstein AL; Marder RJ; Winter JN; Fox RI
J Immunol; 1984 Aug; 133(2):1028-36. PubMed ID: 6376628
[TBL] [Abstract][Full Text] [Related]
60. T cell receptor gene rearrangements in B-precursor acute lymphoblastic leukemia correlate with age and the stage of B cell differentiation.
Nuss R; Kitchingman G; Cross A; Zipf TF; Antoun GR; Bernstein I; Behm F; Pullen DJ; Crist W; Mirro J
Leukemia; 1988 Nov; 2(11):722-7. PubMed ID: 2972889
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
